IQVIA Holdings, Inc. (IQV): Price and Financial Metrics


IQVIA Holdings, Inc. (IQV): $247.29

-1.79 (-0.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

IQV POWR Grades


  • Growth is the dimension where IQV ranks best; there it ranks ahead of 99.34% of US stocks.
  • The strongest trend for IQV is in Momentum, which has been heading down over the past 31 weeks.
  • IQV's current lowest rank is in the Quality metric (where it is better than 42.65% of US stocks).

IQV Stock Summary

  • With a market capitalization of $47,738,965,220, Iqvia Holdings Inc has a greater market value than 94.49% of US stocks.
  • With a one year PEG ratio of 524.2, Iqvia Holdings Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 92.98% of US stocks.
  • With a price/earnings ratio of 116.72, Iqvia Holdings Inc P/E ratio is greater than that of about 92.77% of stocks in our set with positive earnings.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Iqvia Holdings Inc are ROST, NXPI, KDP, IDXX, and GPN.
  • IQV's SEC filings can be seen here. And to visit Iqvia Holdings Inc's official web site, go to www.iqvia.com.

IQV Valuation Summary

  • In comparison to the median Healthcare stock, IQV's EV/EBIT ratio is 137.08% higher, now standing at 63.3.
  • IQV's price/sales ratio has moved up 2.9 over the prior 100 months.
  • Over the past 100 months, IQV's price/sales ratio has gone up 2.9.

Below are key valuation metrics over time for IQV.

Stock Date P/S P/B P/E EV/EBIT
IQV 2019-07-23 2.9 4.7 124.7 55.0
IQV 2019-04-18 2.5 3.9 101.5 49.7
IQV 2017-02-08 3.2 -61.4 48.4 30.8
IQV 2016-05-12 1.3 -18.0 19.2 13.6
IQV 2014-06-24 1.3 -12.3 25.6 17.0
IQV 2013-06-26 1.0 -3.7 27.4 16.8

IQV Growth Metrics

  • Its 2 year price growth rate is now at 44%.
  • Its 5 year net cashflow from operations growth rate is now at 179.25%.
  • Its 2 year net cashflow from operations growth rate is now at 33.85%.
IQV's revenue has moved up $1,713,000,000 over the prior 30 months.

The table below shows IQV's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 12,014 2,663 409
2020-12-31 11,359 1,959 279
2020-09-30 10,956 1,792 176
2020-06-30 10,939 1,548 132
2020-03-31 11,158 1,467 215
2019-12-31 11,088 1,417 191

IQV Stock Price Chart Interactive Chart >

Price chart for IQV

IQV Price/Volume Stats

Current price $247.29 52-week high $254.05
Prev. close $249.08 52-week low $146.00
Day low $243.93 Volume 1,293,800
Day high $249.85 Avg. volume 969,777
50-day MA $242.39 Dividend yield N/A
200-day MA $200.98 Market Cap 47.40B

IQVIA Holdings, Inc. (IQV) Company Bio


IQVIA provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through two segments, Product Development and Integrated Healthcare Services. The company was founded in 1982 and is based in Durham, North Carolina.

IQV Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$247.29$379.11 59%

We started the process of determining a valid price forecast for Iqvia Holdings Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Iqvia Holdings Inc ranked in the 65th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. In terms of the factors that were most noteworthy in this DCF analysis for IQV, they are:

  • The company's compound free cash flow growth rate over the past 5.74 years comes in at 0.39%; that's greater than 75.1% of US stocks we're applying DCF forecasting to.
  • The weighted average cost of capital for the company is 9. This value is greater than merely 24.79% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%56%
1%57%
2%59%
3%60%
4%62%
5%63%

Want more companies with a valuation profile/forecast similar to that of Iqvia Holdings Inc? See BDX, MOH, SYNH, MGLN, and SGRY.


IQV Latest News Stream


Event/Time News Detail
Loading, please wait...

IQV Latest Social Stream


Loading social stream, please wait...

View Full IQV Social Stream

Latest IQV News From Around the Web

Below are the latest news stories about Iqvia Holdings Inc that investors may wish to consider to help them evaluate IQV as an investment opportunity.

What's in Store for IQVIA Holdings (IQV) in Q2 Earnings?

IQVIA's (IQV) second-quarter 2021 earnings and revenues are expected to have improved year over year.

Yahoo | July 23, 2021

NHS shares English hospital data with dozens of companies

More than 40 companies, ranging from the world’s largest management consultancies to pharmaceutical groups, have received years of detailed medical records from English hospitals, a Financial Times analysis has found. At least 100 different NHS data sets have been shared, ranging from the Hospital Episode Statistics (HES) database — which lists every patient admitted, their diagnosis, treatment and any outpatient appointments — to narrower sets of data on emergency care, mental health, mortality, sexual health and maternity services. Last month, the health department released a draft strategy promising to improve access to NHS patient data for researchers, so they can “provide innovative solutions” on everything from drug discovery to shielding programmes.

Yahoo | July 23, 2021

Consumer Health Apps and Digital Health Tools Proliferate, Improving Quality and Health Outcomes for Patients, Says New Report from IQVIA Institute

RESEARCH TRIANGLE PARK, N.C., July 22, 2021--Digital health tools are increasingly having a positive impact on health outcomes. Some are becoming integral parts of mainstream medicine, according to findings released today by the IQVIA Institute for Human Data Science in a new report, Digital Health Trends 2021: Innovation, Evidence, Regulation, and Adoption.

Yahoo | July 22, 2021

Zacks Industry Outlook Highlights: IQVIA Holdings, Seagate Technology and Blucora

Zacks Industry Outlook Highlights: IQVIA Holdings, Seagate Technology and Blucora

Yahoo | July 22, 2021

3 Technology Services Stocks to Watch Out For Despite Industry Woes

The coronavirus-driven dependency on technology, increased digitization and growing adoption of the multi-cloud model should help the Zacks Technology Services industry thrive. IQV, STX and BCOR are well positioned to witness demand surge.

Yahoo | July 21, 2021

Read More 'IQV' Stories Here

IQV Price Returns

1-mo 0.79%
3-mo 4.78%
6-mo 38.41%
1-year 52.38%
3-year 105.31%
5-year 217.36%
YTD 38.02%
2020 15.96%
2019 33.00%
2018 18.66%
2017 28.73%
2016 10.76%

Continue Researching IQV

Here are a few links from around the web to help you further your research on Iqvia Holdings Inc's stock as an investment opportunity:

Iqvia Holdings Inc (IQV) Stock Price | Nasdaq
Iqvia Holdings Inc (IQV) Stock Quote, History and News - Yahoo Finance
Iqvia Holdings Inc (IQV) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9986 seconds.